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ABSTRACT: An efficient synthesis of substituted isocanthines has been achieved using an intramolecular Rh(III)-catalyzed C─H 
functionalization of alkyne-tethered indoles in the presence of catalytic tris(acetonitrile)pentamethyl-cyclopentadienylrhodium(III) 
hexafluoroantimonate and stoichiometric copper(II) acetate. This isocanthine synthesis tolerates a variety of electronically diverse 
5- or 6-substituted indoles with N-tethered alkyne coupling partners and can also be extended to pyrrole derivatives for the synthe-
sis of annulated 5-azaindoles.  
INTRODUCTION 
Isocanthines are a class of tetracyclic γ-carbolines that have 
demonstrated widespread clinical use as cardiovascular 
agents,1 antiemetic 5-HT3 receptor antagonists for 
chemotherapy patients,2 as well as potential treatments for 
CNS disorders.3 Surprisingly, very few syntheses of 
isocanthines (Scheme 1) have been reported. Typically the 
reported syntheses employ either thermal cyclization of a 1-
azatriene4 (Scheme 1, A) or intramolecular hetero-Diels-Alder 
cycloaddition5 of an alkyne-tethered indole oxime (Scheme 1, 
B).6 Unfortunately, these syntheses suffer from very limited 
scope, the requirement of high reaction temperatures, or low 
yield over multiple steps.4,6 Larock’s isocanthine synthesis7 
employing a Pd-catalyzed intramolecular iminoannulation 
affords excellent yields with a wide functional group 
tolerance, but requires pre-installation of a halide, thus is not 
very efficient (Scheme 1, C). Therefore, a more direct 
synthesis of isocanthines is highly desirable. 
Recently, Rh-catalyzed C─H functionalization reactions8 
have attracted much attention in the literature and have been 
employed in synthesizing an array of interesting heterocycles, 
such as indoles,9 isoquinolines,10,11 isoquinolones,12 pyrroles,13 
pyridines14 and polyheterocycles.15 Inspired by Fagnou’s 
isoquinoline synthesis10 from aryl aldimines and alkynes (eq 
1), we envisioned that isocanthines could readily be 
synthesized by C─H functionalization of alkyne-tethered 
indole tert- 
 
butylimines (Scheme 1, D). Herein, we wish to report an 
efficient synthesis of substituted isocanthines via 
intramolecular Rh(III)-catalyzed C─H functionalization of 
alkyne-tethered indoles.   
Scheme 1. Synthetic strategies to Isocanthines 
 
RESULTS AND DISCUSSION 
Our investigation commenced with the optimization of 3-n-
butyl-isocanthine (1a) formation from imine 2a by screening a 
variety of catalyst and oxidant systems (Table 1). The optimal 
“standard conditions” employed 2.5 mol % 
tris(acetonitrile)pentamethylcyclopentadienylrhodium(III) 
hexafluoroantimonate (C1)16 as the catalyst, 2.1 equiv of  
Cu(OAc)2 as the oxidant and the reaction was carried out in 
dichloroethane (DCE) in a sealed vial at 100 °C for 16 h. 
Under this set of optimal conditions, the reaction afforded 
93% conversion and 73% assay yield based on quantitative 
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HPLC analysis. The desired product (1a) was subsequently 
isolated in 73% yield (Table 1, entry 1). When the reaction 
was performed at a lower temperature (83 °C), much lower 
conversion and assay yield were obtained (Table 1, entry 2). 
Without Rh complex C1, the reaction did not produce any 
desired product 1a, which indicates that formation of the 
isocanthine did not proceed via simple thermal hetero-Diels-
Alder cycloaddition and subsequent oxidative aromatization 
(Table 1, entry 3). Lowering the loading of C1 to 1 mol % 
resulted in low conversion and assay yield of product 1a 
(Table 1, entry 4). When [Cp*RhCl2]2 (C2) and [Rh(COD)Cl]2 
(C3) were employed, both reactions proceeded with inferior 
conversion relative to the optimal conditions (Table 1, entries 
5−6). Palladium catalysts, such as palladium(II) acetate (C4) 
and palladium(II) trifluoroacetate (C5), did not generate 
significant conversion (Table 1, entries 7−8).  Among the 
oxidants that were screened, Cu(OAc)2•H2O which was used 
in Fagnou’s isoquinoline synthesis10 resulted in 86% 
conversion and 68% assay yield of the desired product (Table 
1, entry 9). The lower yield was possibly due to partial 
hydrolysis of imine 2a to the corresponding aldehyde under 
the reaction conditions since about 8% of the aldehyde was 
observed upon reaction completion based on HPLC analysis as 
opposed to <2% of the aldehyde when anhydrous Cu(OAc)2 
was employed. Other oxidants, for example, silver acetate, 
benzoquinone and (diacetoxyiodo)benzene all produced low 
assay yield of product 1a (Table 1, entries 10−12). 
Table 1. Optimization of Isocanthine 1a Formation
a
 
 
entry 
variation from the “standard” 
conditions 
conv 
(%)b 
yield 
(%)c 
1 None 93 73(73) 
2 83 °C instead of 100 °C 53 39 
3 no C1 0 0 
4 C1 (1 mol %) as catalyst 20 19 
5 C2 (1.25 mol %) as catalyst 29 25 
6 C3 (1.25 mol %) as catalyst < 5 < 5 
7 C4 as catalyst  < 5 < 5 
8 C5 as catalyst < 5 < 5 
9 Cu(OAc)2•H2O as oxidant 86 68 
10 AgOAc as oxidant 30 27 
11 benzoquinone as oxidant 50 <5 
12 PhI(OAc)2 as oxidant 61 < 5 
aAll reactions were performed using 0.50 mmol of 2a in DCE (3.0 
mL) in sealed vials for 16 h. bDetermined by HPLC analysis. 
cAssay yields determined by quantitative HPLC analysis. The 
number in parentheses is the isolated yield.  
     We next examined the substrate scope and limitations of 
this Rh(III)-catalyzed isocanthine synthesis. It is worth 
mentioning that the transformation of the aldehydes to the 
corresponding tert-butylimines is essentially quantitative, thus 
requiring no further purification and characterization of the 
starting imines used for the subsequent C─H functionalization. 
Indeed, the one-pot imine formation/C─H functionalization 
process employing aldehyde 3a afforded the same isolated 
yield (73%) as that of the step-wise approach (Table 2, entry 
1). Therefore, by employing a one-pot protocol, namely imine 
formation, followed by Rh(III)-catalyzed intramolecular C─H 
functionalization, we were able to synthesize a variety of 
substituted isocanthines (Table 2). 
     The electronic effects of the substituents on the indole ring 
were first examined. Gratifyingly, both electron-donating and 
withdrawing substituents are well tolerated on the 5-position 
of indole. For example, electron-donating methyl and methoxy 
substituted indoles 3b and 3c produced the desired 
isocanthines (1b and 1c) in 78% and 75% yields, respectively 
(Table 2, entries 2−3). Indole 3d substituted with an electron-
withdrawing fluorine atom afforded isocanthine 1d in an 
excellent 90% yield (Table 2, entry 4). 5-Bromo-substituted 
indole 3e also participated in this C─H functionalization 
reaction, generating a moderate yield (40%) of the desired 
bromoisocanthine 1e. (Table 2, entry 5). As expected, indoles 
substituted with either electron-donating (MeO, 3f) or 
electron-withdrawing (CO2Me, 3g) groups at the 6-position 
uneventfully gave the desired products 1f and 1g in 78% and 
82%, respectively (Table 2, entries 6−7).  
Table 2. Scope of Isocanthine Formationa 
 
entry indole product 
yield 
(%)b 
 
  
 
1 
2 
3 
4 
5 
3a, R = H 
3b, R = Me 
3c, R = MeO 
3d, R = F 
3e, R = Br 
1a 
1b 
1c 
1d 
1e 
73 
78 
75 
90 
40c 
 
  
 
 
 
 
6 
7 
3f, R = OMe  
3g, R = CO2Me 
1f 
1g 
78 
82 
 
  
 
8 
9 
10d 
11 
3h, R = CH2OCH3 
3i, R = (CH2)3OTHP 
3j, R = Ph 
3k, R = (CH2)3Ph 
1h 
1i 
1j 
1k 
66 
85 
<5 
87 
 
  
 
 
 
12 
13 
3l, R = H 
3m, R = CO2Me 
1l 
1m 
53 
71 
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  aAll reactions were performed using 0.50 mmol of 3 in t-BuNH2 
(3.0 mL) at 80 °C for 2 h, followed by [Cp*Rh(MeCN)3](SbF6)2 
(C1, 2.5 mol %), Cu(OAc)2 (2.1 equiv) in DCE (3.0 mL) at 100 
°C in sealed vials for 16 h. bIsolated yield. c30A% of isocanthine 
1a was observed by HPLC. dReaction performed at 150 °C. 
  The substituent effect on the alkyne was then investigated. 
Indoles with ether substituted alkynes underwent the 
intramolecular annulation smoothly, giving the desired 
isocanthine products (1h and 1i) in good yields (Table 2, 
entries 8−9). Surprisingly, indole 3j tethered with a phenyl-
substituted alkyne failed to produce isocanthine product 1j 
even at an elevated temperature 150 °C (Table , entry 10).17 
However, indole 3k tethered with a phenylpropyl-substituted 
alkyne uneventfully afforded 87% yiled of isocanthine 1k 
(Table 2, entry 11). This isocanthine synthesis could also be 
extended to alkyne-tethered pyrroles for the synthesis of 
annulated 5-azadindoles.  In fact, pyrroles 3l and 3m were 
subjected to the standard reaction conditions, producing 53% 
and 71% yields of the desired 5-azaindoles (1l and 1m), 
respectively (Table 2, entries 12−13). Thus, one can envision 
that this chemistry could be further expanded into a general 
method for the synthesis of a wide spectrum of annulated 5-
azaindoles. 
     To further demonstrate the synthetic utility of the bromine-
functionalized isocanthine, 1d was converted to cyclopropyl- 
and 2-furyl-substituted derivatives 4a‒b in moderate to good 
yields via Suzuki-Miyaura cross-coupling reactions (Scheme 
2).18 The strucure of isocanthine 4b was established 
unambiguously by single-crystal X-ray diffraction analysis. 
Scheme 2. Synthetic Utility of Bromoisocanthine 1d
a 
  
 
aConditions: (4a), Pd(OAc)2 (10 mol %), di(1-adamanyl)-n-
butylphosphine (15 mol %), Cs2CO3 (3.0 equiv), c-PrBF3K (1.5 
equiv), PhMe:H2O (10:1), 100 °C. (4b), Pd(dtbpp)Cl2 (5 mol %), 
2-furyl pinacol ester (1.5 equiv), K3PO4•H2O (2 equiv), THF:H2O 
(5:1), 65 °C. 
     We conducted DFT calculations using imine 2a as an 
example to assist in understanding the mechanism of this C─H 
functionalization reaction. The free energy profile of the 
Rh(III)/Rh(I) catalytic cycle begining from imine 2a and 
rhodaycle Rh0 is shown in Figure 1. In accord with literature 
precedent,10 the mechanism involves an initial imine 
coordination of 2a and rhodacycle Rh0 to form rhodacycle 
Int1, followed by ortho-directed C─H functionalization via 
concerted metalation deprotonation9,12a (via Int2), then alkyne 
coordination (via Int3) and insertion to afford seven-
membered rhodacycle Int4. TS1 and TS2 are the transition 
states for these two steps, and have barriers of 16.4 and 9.2 
kcal/mol, respectively. Rhodacycle Int4 then undergoes 
reductive elimination via TS3 with a barrier of 17.2 kcal/mol 
to produce intermediate Int5. Int5 then proceeds with tert-
butyl fragmentation and catalyst regeneration in the presence 
of 2 equivalents of Cu(OAc)2 to generate the isocanthine 
product 1a, along with byproducts isobutene, acetic acid and 
Cu(OAc), and catalyst Rh0.      
CONCLUSIONS 
In summary, we have developed a C─H functionalization 
approach to substituted isocanthines from alkyne-tethered 
indole-3-carboxaldehydes and tert-butylamine using 2.5 mol 
% of [Cp*Rh(MeCN)3](SbF6)2 as the catalyst and 2.1 equiv of 
Cu(OAc)2 as the oxidant in DCE at 100 °C. Both electron-
donating and electron-withdrawing substituents are tolerated 
on the 5- and 6-positions of the indole ring. This chemistry can 
also be extended to pyrrole derivatives for the synthesis of 
annulated 5-azaindoles. Bromine substitution on the indole 
ring allows for further functionalization of the isocanthine 
framework via Suzuki-Miyaura cross-coupling reactions. 
Theoretical calculations suggest that the mechanism of this 
chemistry involves ortho-directed C─H functionalization via a 
concerted metalation deprotonation pathway, followed by 
alkyne coordination and insertion, then reductive elimination 
and tert-butyl fragmentation to afford the desired isocanthine 
product.  
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Figure 1. (a) Free energy profiles for the mechanism of Rh(III)-catalyzed formation of isocanthine 1a. (b) Computed configurations of 
transition states with selected bond distances shown in angstroms (Å). Some hydrogen atoms are omitted for clarity. 
EXPERIMENTAL SECTION 
Materials and Methods 
Unless stated otherwise, reactions were performed in 4-dram vi-
als sealed with Teflon-lined caps. Commercially obtained solvents 
and reagents were used as received. Thin-layer chromatography 
(TLC) was performed using glass-backed plates pre-coated with 
EMD silica gel 60 F254 and visualized using UV light (254 nm). 
1H 
and 13C NMR spectra were recorded on 300 or 400 MHz Bruker 
spectrometer and chemical shifts are reported relative to the residual 
solvent peak (1H NMR, δ 7.26 for CDCl3, 
13C NMR, δ 77.0 for 
CDCl3). 
1H NMR spectral data are reported in terms of: chemical 
shift (δ ppm), multiplicity, coupling constant (Hz), and integration. 
13C NMR spectral data are reported in terms of chemical shift (δ 
ppm). Flash column chromatography was performed using a Com-
biFlash ISCO instrument, using pre-packed RediSep silica gel col-
umns. HPLC analyses were performed using an Agilent 1290 Infini-
ty Series HPLC instrument. IR spectra were recorded using a 
Bruker Alpha Platinum-ATR spectrometer and are reported in 
wavenumbers (cm−1). HRMS data were obtained using a LTQ Or-
bitrap Discovery (Thermo Fisher Scientific) at Genentech, Inc.  
Melting points were measured on a Büchi Melting Point B-540 
apparatus. 
General Experimental Procedure 
 (8-Chlorooct-4-yn-1-yl)benzene: To a flame-dried 50 mL 
round-bottom flask was added 5-chloropent-1-yne (0.968 g, 9.44 
mmol), followed by THF (9.4 mL), and the mixture was cooled to ‒
78 ºC under N2. n-Butyllithium solution (2.5 M in hexanes, 4.2 mL, 
1.1 equiv) was then added dropwise, and the mixture was stirred at 
‒78 ºC for 30 min before dropwise addition of (3-
iodopropyl)benzene (1.5 mL, 9.44 mmol, 1.0 equiv). The mixture 
was stirred at ‒78 ºC for 30 min, warmed to 23 °C and stirred at 23 
°C for 16 h. The reaction was quenched with saturated aqueous 
ammonium chloride and the aqueous layer was extracted with ethyl 
acetate (10 mL, ×3). The combined organic layers were washed 
with brine (10 mL), dried over sodium sulfate (2 g), concentrated in 
vacuum and purified by silica gel column chromatography using 
ethyl acetate in hexanes (0‒2%) to afford (8-chlorooct-4-yn-1-
yl)benzene as a colorless oil (1.27 g, 61%); FTIR (thin film, cm−1) 
3026, 2940, 2859, 1603, 1453; 1H NMR (400 MHz, CDCl3) δ 7.32 
– 7.26 (m, 2H), 7.19 (ddd, J = 6.1, 2.1, 1.2 Hz, 3H), 3.67 (t, J = 6.4 
Hz, 2H), 2.75 – 2.67 (m, 2H), 2.37 (tt, J = 6.7, 2.4 Hz, 2H), 2.17 (tt, 
J = 7.1, 2.4 Hz, 2H), 1.95 (quintet, J = 6.5 Hz, 2H), 1.87 – 1.75 (m, 
2H); 13C NMR (101 MHz, CDCl3) δ 141.9, 128.7, 128.5, 126.0, 
81.1, 78.8, 44.0, 35.0, 31.9, 30.8, 18.3, 16.4; HRMS (ESI-TOF) 
m/z: [M + H]+ calcd for C14H18Cl 221.1097; Found, 221.1071. 
Synthesis of N-Alkylated Indole-3-carboxaldehydes  
To a 20 mL vial was added indole-3-carboxaldehyde, sodium io-
dide (1.5 equiv), cesium carbonate (1.5 equiv), and chloroalkyne 
(1.2 equiv) in acetonitrile (10 mL/g). The vial was then sealed and 
heated to 80 °C. After 16 h, solids were filtered off and the cake was 
washed with acetonitrile (2 mL/g, ×3). The combined organic solu-
tion was concentrated and purified by silica gel column chromatog-
raphy with ethyl acetate in hexanes gradient eluent to afford the 
desired N-alkylated indole-3-carboxaldehyde 3. 
1-(Non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3a): 1H-indole-
3-carbaldehyde (1.00 g, 6.89 mmol), sodium iodide (1.55 g, 1.5 
equiv), cesium carbonate (3.37 g, 1.5 equiv), 1-chloronon-4-yne 
(1.31 g, 1.2 equiv) and acetonitrile (10.0 mL) were employed. Upon 
silica gel column chromatography purification using ethyl acetate in 
hexanes (0‒50%), compound 3a was isolated as a yellow oil (1.79 
g, 97%). FTIR (thin film, cm−1) 2956, 2930, 1655, 1531, 1467; 1H 
NMR (300 MHz, CDCl3) δ 10.02 (s, 1H), 8.35 – 8.28 (m, 1H), 7.77 
(s, 1H), 7.47 – 7.28 (m, 3H), 4.35 (t, J = 6.7 Hz, 2H), 2.26 – 2.15 
(m, 4H), 2.04 (quintet, J = 6.4 Hz, 2H), 1.58 – 1.38 (m, 4H), 0.94 (t, 
J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 184.4, 138.9, 137.2, 
125.4, 123.9, 122.8, 122.0, 118.0, 110.2, 82.3, 77.8, 45.6, 31.1, 
28.7, 22.0, 18.4, 16.0, 13.7; HRMS (ESI-TOF) m/z: [M + H]+ calcd 
for C18H22NO 268.1701; Found, 268.1703. 
5-Methyl-1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3b): 5-
methyl-1H-indole-3-carbaldehyde (500 mg, 3.14 mmol), sodium 
iodide (471 mg, 1.5 equiv), cesium carbonate (1.54 g, 1.5 equiv), 1-
chloronon-4-yne (598 mg, 1.2 equiv) and acetonitrile (5.0 mL) were 
employed. Upon silica gel column chromatography purification 
using ethyl acetate in hexanes (0‒50%), compound 3b was isolated 
as a yellow oil (857 mg, 97%). FTIR (thin film, cm−1) 2954, 2930, 
1652, 1528, 1485; 1H NMR (300 MHz, CDCl3) δ 9.98 (s, 1H), 8.12 
(s, 1H), 7.72 (s, 1H), 7.31 (d, J = 8.4 Hz, 1H), 7.16 (dd, J = 8.4, 1.4 
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5
Hz, 1H), 4.32 (t, J = 6.7 Hz, 2H), 2.49 (s, 3H), 2.25 – 2.13 (m, 4H), 
2.02 (quintet, J = 6.4 Hz, 2H), 1.57 – 1.38 (m, 4H), 0.94 (t, J = 7.1 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 184.4, 138.8, 135.5, 132.6, 
125.7, 125.4, 121.8, 117.7, 109.8, 82.3, 77.8, 45.7, 31.1, 28.7, 22.0, 
21.4, 18.4, 16.0, 13.6; HRMS (ESI-TOF) m/z: [M + H]+ calcd for 
C19H24NO 282.1858; Found, 282.1861. 
5-Methoxy-1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3c): 
5-methoxy-1H-indole-3-carbaldehyde (600 mg, 3.43 mmol), sodium 
iodide (771 mg, 1.5 equiv), cesium carbonate (1.67 g, 1.5 equiv), 1-
chloronon-4-yne (653 mg, 1.2 equiv) and acetonitrile (6.0 mL) were 
employed. Upon silica gel column chromatography purification 
using ethyl acetate in hexanes (0‒50%), compound 3c was isolated 
as a white solid (927 mg, 91%). M.p. 61‒63 °C; FTIR (thin film, 
cm−1) 2955, 2930, 1652, 1530, 1389; 1H NMR (300 MHz, CDCl3) δ 
9.96 (s, 1H), 7.80 (d, J = 2.5 Hz, 1H), 7.71 (s, 1H), 7.30 (d, J = 8.9 
Hz, 1H), 6.97 (dd, J = 8.9, 2.5 Hz, 1H), 4.31 (t, J = 6.7 Hz, 2H), 
3.90 (s, 3H), 2.26 – 2.14 (m, 4H), 2.02 (quintet, J = 6.5 Hz, 2H), 
1.48 (m, 4H), 0.94 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δ 184.4, 156.6, 138.8, 132.0, 126.1, 117.8, 114.3, 110.9, 103.4, 
82.3, 77.8, 55.7, 45.8, 31.1, 28.7, 22.0, 18.4, 16.0, 13.6; HRMS 
(ESI-TOF) m/z: [M + H]+ calcd for C19H24NO2 298.1807; Found, 
298.1809. 
5-Fluoro-1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3d): 5-
fluoro-1H-indole-3-carbaldehyde (500 mg, 3.07 mmol), sodium 
iodide (690 mg, 1.5 equiv), cesium carbonate (1.50 g, 1.5 equiv), 1-
chloronon-4-yne (585 mg, 1.2 equiv) and acetonitrile (5.0 ml) were 
employed. Upon silica gel column chromatography purification 
using ethyl acetate in hexanes (0‒50%), compound 3d was isolated 
as a yellow oil (791 mg, 91%). FTIR (thin film, cm−1) 2955, 2930, 
1655, 1531, 1392; 1H NMR (300 MHz, CDCl3) δ 9.98 (s, 1H), 7.99 
(dd, J = 9.2, 2.5 Hz, 1H), 7.78 (s, 1H), 7.35 (dd, J = 9.0, 4.2 Hz, 
1H), 7.07 (td, J = 9.0, 3.8 Hz, 1H), 4.34 (t, J = 6.7 Hz, 2H), 2.25 – 
2.14 (m, 4H), 2.03 (quintet, J = 6.5 Hz, 2H), 1.47 (m, 4H), 0.94 (t, J 
= 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 184.2, 159.7 (d, J = 
319 Hz), 139.7, 133.6, 125.9 (d, J = 11.0 Hz), 117.8 (d, J = 4.5 Hz), 
112.2 (d, J = 26.4 Hz), 111.0 (d, J = 9.8 Hz), 107.4 (d, J = 24.6 Hz), 
82.4, 77.6, 45.9, 31.1, 28.6, 22.0, 18.4, 15.9, 13.6; HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C18H21FNO 286.1607; Found, 
286.1616. 
5-Bromo-1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3e): 5-
bromo-1H-indole-3-carbaldehyde (500 mg, 2.23 mmol), sodium 
iodide (501 mg, 1.5 equiv), cesium carbonate (1.09 g, 1.5 equiv), 1-
chloronon-4-yne (425 mg, 1.2 equiv) and acetonitrile (5.0 mL) were 
employed. Upon silica gel column chromatography purification 
using ethyl acetate in hexanes (0‒50%), compound 3e was isolated 
as a white solid (678 mg, 88%). M.p. 74‒75 °C; FTIR (thin film, 
cm−1) 2955, 2931, 1662, 1531, 1465, 1401; 1H NMR (300 MHz, 
CDCl3) δ 9.98 (s, 1H), 8.48 (d, J = 1.9 Hz, 1H), 7.75 (s, 1H), 7.43 
(dd, J = 8.7, 1.9 Hz, 1H), 7.30 (d, J = 8.7 Hz, 1H), 4.33 (t, J = 6.7 
Hz, 2H), 2.26 – 2.12 (m, 4H), 2.02 (quintet, J = 6.4 Hz, 2H), 1.55 – 
1.35 (m, 4H), 0.94 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δ 184.2, 139.0, 135.8, 127.0, 126.9, 124.8, 117.5, 116.6, 111.5, 
82.6, 77.5, 45.9, 31.1, 28.6, 22.0, 18.4, 16.0, 13.6; HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C18H21BrNO 346.0807; Found, 
346.0821. 
6-Methoxy-1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (3f): 
6-methoxy-1H-indole-3-carbaldehyde (296 mg, 1.69 mmol,), sodi-
um iodide (380 mg, 1.5 equiv), cesium carbonate (826 mg, 1.5 
equiv), 1-chloronon-4-yne (268 mg, 1.0 equiv) and acetonitrile (3.4 
mL) were employed. Upon silica gel column chromatography puri-
fication using ethyl acetate in hexanes (0‒30%), compound 3f was 
isolated as a yellow solid (264 mg, 53%); M.p.  38‒40 °C; FTIR 
(thin film, cm−1) 2928, 2858, 1656, 1623, 1578, 1523; 1H NMR 
(400 MHz, CDCl3) δ 9.94 (s, 1H), 8.18 (d, J = 8.7 Hz, 1H), 7.66 (s, 
1H), 6.96 (dd, J = 8.7, 2.3 Hz, 1H), 6.88 (d, J = 2.1 Hz, 1H), 4.29 (t, 
J = 6.7 Hz, 2H), 3.89 (s, 3H), 2.25 – 2.14 (m, 5H), 2.10 – 1.96 (m, 
2H), 1.54 – 1.38 (m, 4H), 0.93 (t, J = 7.2 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 184.6, 157.7, 138.3, 123.1, 119.6, 118.4, 112.0, 
94.2, 82.6, 77.9, 77.4, 55.9, 45.7, 31.3, 28.7, 22.2, 18.6, 16.2, 13.8; 
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C19H23NO2Na 
320.1626; Found, 320.1621. 
Methyl 3-formyl-1-(non-4-yn-1-yl)-1H-indole-6-carboxylate 
(3g): methyl 3-formyl-1H-indole-6-carboxylate (500 mg, 2.46 
mmol), sodium iodide (553 mg, 1.5 equiv), cesium carbonate (1.20 
g, 1.5 equiv), 1-chloronon-4-yne (468 mg, 1.2 equiv) and acetoni-
trile (5.0 mL) were employed. Upon silica gel column chromatog-
raphy purification using ethyl acetate in hexanes (0‒50%), com-
pound 3g was isolated as a yellow oil (578 mg, 72%). FTIR (thin 
film, cm−1) 2953, 2932, 1711, 1658, 1617, 1529, 1434; 1H NMR 
(300 MHz, CDCl3) δ 10.04 (s, 1H), 8.34 (d, J = 8.3 Hz, 1H), 8.18 (s, 
1H), 8.00 (dd, J = 8.4, 1.4 Hz, 1H), 7.90 (s, 1H), 4.42 (t, J = 6.6 Hz, 
2H), 3.96 (s, 3H), 2.20 (td, J = 7.9, 4.7 Hz, 4H), 2.07 (quintet, J = 
6.6 Hz, 2H), 1.58 – 1.37 (m, 4H), 0.94 (t, J = 7.2 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δ 184.2, 167.2, 140.7, 136.6, 128.8, 125.5, 123.7, 
121.5, 117.9, 112.2, 82.5, 77.5, 52.0, 45.8, 31.0, 28.7, 22.0, 18.3, 
15.9, 13.5; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C20H24NO3  
326.1756; Found, 326.1764. 
1-(6-Methoxyhex-4-yn-1-yl)-1H-indole-3-carbaldehyde (3h): 
1H-indole-3-carbaldehyde (1.22 g, 7.61 mmol), sodium iodide (1.71 
g, 1.5 equiv), cesium carbonate (3.72 g, 1.5 equiv), 6-chloro-1-
methoxyhex-2-yne19 (1.34 g, 1.2 equiv) and acetonitrile (12.2 mL) 
were employed. Upon silica gel column chromatography purifica-
tion using ethyl acetate in hexanes (0‒50%), compound 3h was 
isolated as a yellow oil (1.83 g, 63%). FTIR (thin film, cm−1) 2932, 
2820, 1654, 1530, 1388; 1H NMR (300 MHz, CDCl3) δ 10.02 (s, 
1H), 8.35 – 8.29 (m, 1H), 7.77 (s, 1H), 7.45 – 7.28 (m, 3H), 4.36 (t, 
J = 6.7 Hz, 2H), 4.12 (t, J = 2.1 Hz, 2H), 3.40 (s, 3H), 2.29 – 2.24 
(m, 2H), 2.10 (quintet, J = 6.6 Hz, 2H); 13C NMR (75 MHz, CDCl3) 
δ 184.4, 139.1, 137.1, 125.2, 123.9, 122.7, 121.8, 117.9, 110.2, 
84.7, 77.7, 59.9, 57.4, 45.5, 28.2, 15.9; HRMS (ESI-TOF) m/z: [M 
+ H]+ calcd for C16H18NO2 256.1338; Found, 256.1338. 
1-(8-((Tetrahydro-2H-pyran-2-yl)oxy)oct-4-yn-1-yl)-1H-
indole-3-carbaldehyde (3i): 1H-indole-3-carbaldehyde (1.00 g, 
6.89 mmol), sodium iodide (1.55 g, 1.5 equiv), cesium carbonate 
(3.37 g, 1.5 equiv), 2-((8-chlorooct-4-yn-1-yl)oxy)tetrahydro-2H-
pyran20 (2.02 g, 1.2 equiv) and acetonitrile (9.0 mL) were employed. 
Upon silica gel column chromatography purification using ethyl 
acetate in hexanes (0‒30%), compound 3i was isolated as a yellow 
oil (1.26 g, 52%); FTIR (thin film, cm−1) 2942, 1662, 1616, 1533, 
1468, 1401; 1H NMR (400 MHz, CDCl3) δ 10.02 (s, 1H), 8.35 – 
8.27 (m, 1H), 7.78 (s, 1H), 7.45 – 7.39 (m, 1H), 7.37 – 7.28 (m, 
2H), 4.60 (dd, J = 4.3, 2.8 Hz, 1H), 4.35 (t, J = 6.7 Hz, 2H), 3.91 – 
3.82 (m, 2H), 3.55 – 3.43 (m, 2H), 2.33 (tt, J = 7.1, 2.4 Hz, 2H), 
2.22 – 2.13 (m, 4H), 2.10 – 2.00 (m, 2H), 1.88 – 1.77 (m, 3H), 1.72 
(tt, J = 9.1, 3.2 Hz, 1H), 1.65 – 1.46 (m, 4H); 13C NMR (101 MHz, 
CDCl3) δ 184.7, 138.8, 137.3, 125.6, 124.1, 123.1, 122.4, 118.3, 
110.2, 99.0, 81.9, 78.2, 66.2, 62.5, 45.9, 30.9, 29.4, 28.7, 25.6, 19.7, 
16.2, 15.8; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C22H28NO3 
354.2064; Found, 354.2045. 
1-(5-Phenylpent-4-yn-1-yl)-1H-indole-3-carbaldehyde (3j): 
1H-indole-3-carbaldehyde (200 mg, 1.38 mmol), sodium iodide 
(310 mg, 1.5 equiv), cesium carbonate (674 mg, 1.5 equiv), (5-
chloropent-1-yn-1-yl)benzene7a,21 (296 mg, 1.2 equiv) and acetoni-
trile (2.0 mL) were employed. Upon silica gel column chromatog-
raphy purification using ethyl acetate in hexanes (0‒50%), com-
pound 3j was isolated as a yellow oil (322 mg, 81%). FTIR (thin 
film, cm−1) 3103, 3052, 2942, 2809, 2754, 1654, 1530, 1467; 1H 
NMR (300 MHz, CDCl3) δ 10.02 (s, 1H), 8.36 – 8.30 (m, 1H), 7.80 
(s, 1H), 7.48 – 7.41 (m, 3H), 7.38 – 7.30 (m, 5H), 4.43 (t, J = 6.7 
Hz, 2H), 2.45 (t, J = 6.6 Hz, 2H), 2.19 (p, J = 6.6 Hz, 2H); 13C 
NMR (75 MHz, CDCl3) δ 184.5, 138.6, 137.2, 131.6, 128.4, 128.1, 
125.5, 124.0, 123.3, 123.0, 122.2, 118.2, 110.1, 87.6, 82.5, 45.7, 
28.4, 16.7; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C20H18NO 
288.1388; Found, 288.1399. 
1-(8-Phenyloct-4-yn-1-yl)-1H-indole-3-carbaldehyde (3k): 1H-
indole-3-carbaldehyde (1.07 g, 7.36 mmol), sodium iodide (2.00 g, 
1.5 equiv), cesium carbonate (4.33 g, 1.5 equiv), (8-chlorooct-4-yn-
1-yl)benzene (1.95 g, 1.2 equiv) and acetonitrile (10.0 mL) were 
employed. Upon silica gel column chromatography purification 
using ethyl acetate in hexanes (0‒30%), compound 3k was isolated 
as a yellow oil (1.82 g, 75%); FTIR (thin film, cm−1) 3025, 2935, 
1660, 1614, 1576, 1531; 1H NMR (400 MHz, CDCl3) δ 10.01 (s, 
1H), 8.36 – 8.29 (m, 1H), 7.76 (s, 1H), 7.46 – 7.39 (m, 1H), 7.37 – 
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7.27 (m, 4H), 7.24 – 7.17 (m, 3H), 4.35 (t, J = 6.7 Hz, 2H), 2.75 
(dd, J = 8.3, 6.9 Hz, 2H), 2.28 – 2.16 (m, 4H), 2.11 – 2.01 (m, 2H), 
1.92 – 1.81 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 184.7, 141.7, 
138.7, 137.3, 128.6, 128.5, 126.1, 125.6, 124.1, 123.1, 122.3, 118.3, 
110.2, 82.0, 78.4, 45.9, 35.1, 30.7, 28.8, 18.4, 16.2; HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C23H24NO 330.1852; Found, 
330.1867. 
1-(Non-4-yn-1-yl)-1H-pyrrole-3-carbaldehyde (3l): 1H-
pyrrole-3-carbaldehyde (500 mg, 5.26 mmol), sodium iodide (1.18 
g, 1.5 equiv), cesium carbonate (2.57 g, 1.5 equiv), 1-chloronon-4-
yne (1.00 g, 1.2 equiv) and acetonitrile (5.0 mL) were employed. 
Upon silica gel column chromatography purification using ethyl 
acetate in hexanes (0‒50%), compound 3l was isolated as a yellow 
oil (1.12 g, 98%). FTIR (thin film, cm−1) 2955, 2931, 1664, 1532, 
1397; 1H NMR (300 MHz, CDCl3) δ 9.74 (s, 1H), 7.30 (t, J = 1.8 
Hz, 1H), 6.71 – 6.60 (m, 2H), 4.06 (t, J = 6.7 Hz, 2H), 2.22 – 2.12 
(m, 4H), 1.93 (quintet, J = 6.6 Hz, 2H), 1.54 – 1.35 (m, 4H), 0.93 (t, 
J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 185.1, 129.2, 126.4, 
123.4, 108.1, 82.0, 77.7, 48.5, 31.0, 30.0, 21.9, 18.3, 15.7, 13.5; 
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C14H20NO 218.1545; 
Found, 218.1542. 
Methyl 4-formyl-1-(non-4-yn-1-yl)-1H-pyrrole-2-carboxylate 
(3m): methyl 4-formyl-1H-pyrrole-2-carboxylate (500 mg, 3.27 
mmol), sodium iodide (735 mg, 1.5 equiv), cesium carbonate (1.60 
g, 1.5 equiv), 1-chloronon-4-yne (623 mg, 1.2 equiv) and acetoni-
trile (5.0 mL) were employed. Upon silica gel column chromatog-
raphy purification using ethyl acetate in hexanes (0‒50%), com-
pound 3m was isolated as a yellow oil (857 mg, 95%). FTIR (thin 
film, cm−1) 2955, 2932, 2861, 1713, 1675, 1546, 1419; 1H NMR 
(300 MHz, CDCl3) δ 9.78 (s, 1H), 7.50 (d, J = 1.9 Hz, 1H), 7.38 (d, 
J = 1.9 Hz, 1H), 4.48 (t, J = 6.7 Hz, 2H), 3.84 (s, 3H), 2.22 – 2.10 
(m, 4H), 1.96 (quintet, J = 6.6 Hz, 2H), 1.46 (m, 4H), 0.93 (t, J = 
7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 185.0, 160.8, 133.5, 
124.5, 123.7, 117.7, 81.9, 77.9, 51.4, 48.7, 31.0, 29.8, 21.9, 18.3, 
15.6, 13.5; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C16H22NO3  
276.1600; Found, 276.1610. 
Synthesis of Isocanthines  
To a 4-dram vial was added indole-3-aldehyde 3 (0.50 mmol), in 
tert-butyl amine (3.0 mL). The vial was then sealed with a Teflon-
lined cap, and the mixture was heated to 80 °C for 2 h. After com-
pletion of imine formation (>99% conversion observed by 1H 
NMR), the reaction mixture was cooled to 23 °C, and concentrated 
in vacuum. Catalyst [Cp*Rh(MeCN)3](SbF6)2 (C1, 2.5 mol %, 10.6 
mg), oxidant Cu(OAc)2 (2.1 equiv, 197 mg) and dichloroethane 
(DCE, 3.0 mL) were then added. The mixture was heated to 100 °C 
for 16 h. The mixture was then cooled to 23 °C and quenched with 3 
mL of saturated aqueous NaHCO3 solution. The aqueous layer was 
extracted with dichloromethane (5 mL × 3) and the organic layers 
were combined and concentrated in vacuum. The residue was then 
purified using column chromatography to give the desired isocan-
thine 1.  
3-n-Butyl-5,6-dihydro-4H-indolo[3,2,1-ij][1,6]naphthyridine 
(1a): 1-(non-4-yn-1-yl)-1H-indole-3-carbaldehyde (134 mg, 0.50 
mmol), tert-butylamine (3.0 mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 
10.6 mg, 2.5 mol %), Cu(OAc)2 (197 mg, 2.1 equiv) and dichloro-
ethane (3.0 mL) were employed. Upon silica gel column chroma-
tography purification using MeOH in DCM gradient elution (0‒
10%), compound 1a was isolated as a yellow solid (97 mg, 73%). 
M.p. 61‒63 °C; FTIR (thin film, cm−1) 2951, 2927, 2857, 1604, 
1442; 1H NMR (300 MHz, CDCl3) δ 9.07 (s, 1H), 8.11 (d, J = 7.8 
Hz, 1H), 7.48 (td, J = 7.6, 1.1 Hz, 1H), 7.38 (d, J = 8.1 Hz, 1H), 
7.32 – 7.24 (m, 1H), 4.19 (t, J = 5.8 Hz, 2H), 3.03 (t, J = 6.2 Hz, 
2H), 2.92 (t, J = 7.9 Hz, 2H), 2.35 (quintet, J = 6.0 Hz, 2H), 1.84 – 
1.65 (m, 2H), 1.44 (dq, J = 14.6, 7.3 Hz, 2H), 0.96 (t, J = 7.3 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 153.0, 142.9, 140.1, 139.5, 
125.9, 121.5, 121.0, 120.0, 116.0, 113.1, 108.6, 40.4, 34.1, 32.1, 
22.8, 22.1, 21.5, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for 
C18H21N2 265.1705; Found, 265.1717.  
3-n-Butyl-10-methyl-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1b): 5-methyl-1-(non-4-yn-1-yl)-1H-indole-
3-carbaldehyde (141 mg, 0.50 mmol), tert-butylamine (3.0 mL), 
[Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), Cu(OAc)2 (197 
mg, 2.1 equiv) and dichloroethane (3.0 mL) were employed. Upon 
silica gel column chromatography purification using ethyl acetate in 
hexanes gradient elution (0‒50%), compound 1b was isolated as a 
green solid (109 mg, 78%). M.p. 76‒78 °C; FTIR (thin film, cm−1) 
2951, 2930, 2858, 1632, 1482; 1H NMR (300 MHz, CDCl3) 9.03 (s, 
1H), 7.59 (d, J = 2.4 Hz, 1H), 7.28 (d, J = 9.0 Hz, 1H), 7.11 (dd, J = 
8.8, 2.5 Hz, 1H), 4.15 (t, J = 5.8 Hz, 2H), 3.93 (s, 3H), 3.01 (t, J = 
6.2 Hz, 2H), 2.90 (t, J = 7.9 Hz, 2H), 2.33 (quintet, J = 6.0 Hz, 2H), 
1.82 – 1.67 (m, 2H), 1.44 (dq, J = 14.6, 7.3 Hz, 2H), 0.96 (t, J = 7.3 
Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 154.3, 152.9, 143.3, 139.7, 
135.2, 122.0, 116.0, 114.9, 113.0, 109.2, 104.1, 56.1, 40.5, 34.2, 
32.1, 22.9, 22.2, 21.4, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd 
for C19H23N2  279.1861; Found, 279.1868. 
3-n-Butyl-10-methoxy-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1c): 5-methoxy-1-(non-4-yn-1-yl)-1H-
indole-3-carbaldehyde (149 mg, 0.50 mmol), tert-butylamine (3.0 
mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), 
Cu(OAc)2 (197 mg, 2.1 equiv) and dichloroethane (3.0 mL) were 
employed. Upon silica gel column chromatography purification 
using MeOH in DCM gradient elution (0‒10%), compound 1c was 
isolated as a white solid (111 mg, 75%). M.p. 87‒88 °C; FTIR (thin 
film, cm−1) 2951, 2925, 2857, 1610, 1572, 1483; 1H NMR (300 
MHz, CDCl3) δ 9.02 (s, 1H), 7.90 (s, 1H), 7.32 – 7.24 (m, 2H), 4.15 
(t, J = 5.8 Hz, 2H), 3.01 (t, J = 6.2 Hz, 2H), 2.89 (t, J = 7.9 Hz, 2H), 
2.53 (s, 3H), 2.32 (quintet, J = 6.0 Hz, 2H), 1.80 – 1.67 (m, 2H), 
1.44 (dq, J = 14.6, 7.3 Hz, 2H), 0.96 (t, J = 7.3 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δ 152.9, 143.1, 139.6, 138.5, 129.3, 127.1, 121.7, 
121.1, 115.8, 113.0, 108.2, 40.4, 34.2, 32.2, 22.9, 22.2, 21.5, 21.4, 
14.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C19H23N2O  
295.1810; Found, 295.1820. 
3-n-Butyl-10-fluoro-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1d): 5-fluoro-1-(non-4-yn-1-yl)-1H-indole-
3-carbaldehyde (143 mg, 0.50 mmol), tert-butylamine (3.0 mL), 
[Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), Cu(OAc)2 (197 
mg, 2.1 equiv) and dichloroethane (3.0 mL) were employed. Upon 
silica gel column chromatography purification using ethyl acetate in 
hexanes gradient elution (0‒50%), compound 1d was isolated as a 
white solid (128 mg, 90%). M.p. 101‒103 °C; FTIR (thin film, 
cm−1) 2952, 2929, 2959, 1633, 1572, 1478; 1H NMR (300 MHz, 
CDCl3) δ 9.02 (s, 1H), 7.76 (dd, J = 8.9, 2.4 Hz, 1H), 7.31 – 7.25 
(m, 1H), 7.20 (td, J = 8.9, 2.5 Hz, 1H), 4.16 (t, J = 5.8 Hz, 2H), 3.01 
(t, J = 6.2 Hz, 2H), 2.90 (t, J = 7.9 Hz, 2H), 2.34 (quintet, J = 6.0 
Hz, 2H), 1.79 – 1.67 (m, 4H), 1.44 (dq, J = 14.6, 7.3 Hz, 2H), 0.96 
(t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 157.8 (d, J = 316 
Hz), 153.5, 143.6, 140.0, 136.5, 122.0 (d, J = 9.8 Hz), 115.7 (d, J = 
4.1 Hz), 113.5 (d, J = 25.5 Hz), 108.9 (d, J = 9.2 Hz), 106.9 (d, J = 
24.2 Hz), 40.5, 34.2, 32.1, 22.8, 22.1, 21.3, 14.1; HRMS (ESI-TOF) 
m/z: [M + H]+ calcd for C18H20FN2  283.1611; Found, 283.1622. 
10-Bromo-3-n-butyl-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1e): 5-bromo-1-(non-4-yn-1-yl)-1H-indole-
3-carbaldehyde (173 mg, 0.50 mmol), tert-butylamine (3.0 mL), 
[Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), Cu(OAc)2 (197 
mg, 2.1 equiv) and dichloroethane (3.0 mL) were employed. Upon 
silica gel column chromatography purification using ethyl acetate in 
hexanes gradient elution (0‒50%), compound 1e was isolated as a 
pale yellow solid (70 mg, 40%); M.p. 96‒98 °C; FTIR (thin film, 
cm−1) 2945, 2851, 1628, 1570, 1450; 1H NMR (400 MHz, CDCl3) δ 
9.02 (d, J = 0.7 Hz, 1H), 8.21 (dd, J = 2.0, 0.5 Hz, 1H), 7.55 (dd, J 
= 8.6, 1.9 Hz, 1H), 7.27 – 7.19 (m, 1H), 4.23 – 4.05 (m, 2H), 3.08 – 
2.95 (m, 2H), 2.93 – 2.80 (m, 2H), 2.41 – 2.24 (m, 2H), 1.81 – 1.64 
(m, 3H), 1.44 (dq, J = 14.8, 7.3 Hz, 2H), 0.96 (t, J = 7.3 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 153.9, 143.2, 140.0, 138.8, 128.6, 
123.8, 123.3, 115.2, 113.3, 112.8, 109.9, 40.6, 34.2, 32.1, 22.9, 
22.1, 21.4, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for 
C18H20BrN2 343.0810; Found, 343.0826.  
3-n-Butyl-9-methoxy-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1f): 6-methoxy-1-(non-4-yn-1-yl)-1H-
indole-3-carbaldehyde (149 mg, 0.50 mmol), tert-butylamine (3.0 
mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), 
Cu(OAc)2 (197 mg, 2.1 equiv) and dichloroethane (3.0 mL) were 
employed. Upon silica gel column chromatography purification 
using MeOH in DCM gradient elution (0‒10%), compound 1f was 
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7
isolated as a white solid (115 mg, 78%). M.p. 90‒92 °C; FTIR (thin 
film, cm−1) 2952, 2930, 2857, 1609, 1578, 1475; 1H NMR (300 
MHz, CDCl3) δ 8.96 (s, 1H), 7.96 (d, J = 8.5 Hz, 1H), 6.90 – 6.83 
(m, 2H), 4.13 (t, J = 5.8 Hz, 2H), 3.93 (s, 3H), 3.01 (t, J = 6.2 Hz, 
2H), 2.89 (t, J = 7.9 Hz, 2H), 2.33 (quintet, J = 6.0 Hz, 2H), 1.72 
(m, 2H), 1.44 (dq, J = 14.6, 7.3 Hz, 2H), 0.96 (t, J = 7.3 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 159.2, 152.3, 143.2, 141.6, 138.7, 
121.7, 116.2, 115.2, 112.9, 108.1, 93.2, 55.7, 40.5, 34.2, 32.2, 22.9, 
22.2, 21.5, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for 
C19H23N2O  295.1810; Found, 295.1823. 
Methyl 3-n-butyl-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine-9-carboxylate (1g): methyl 3-formyl-1-(non-
4-yn-1-yl)-1H-indole-6-carboxylate (163 mg, 0.50 mmol), tert-
butylamine (3.0 mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 
mol %), Cu(OAc)2 (197 mg, 2.1 equiv) and dichloroethane (3.0 mL) 
were employed. Upon silica gel column chromatography purifica-
tion using MeOH in DCM gradient elution (0‒10%), compound 1g 
was isolated as a white solid (133 mg, 82%); M.p. 135‒137 °C; 
FTIR (thin film, cm−1) 3073, 2947, 2865, 2853, 1612, 1567, 1440; 
1H NMR (400 MHz, CDCl3) δ 9.11 (s, 1H), 8.18 – 8.07 (m, 2H), 
7.98 (dd, J = 8.1, 1.5 Hz, 1H), 4.25 (dd, J = 6.3, 5.3 Hz, 2H), 3.99 
(s, 3H), 3.05 (t, J = 6.2 Hz, 2H), 2.98 – 2.81 (m, 2H), 2.43 – 2.29 
(m, 2H), 1.80 – 1.69 (m, 2H), 1.44 (sextet, J = 7.4 Hz, 2H), 0.97 (t, 
J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.6, 154.3, 
144.2, 140.7, 139.7, 127.4, 125.5, 121.3, 120.7, 115.5, 113.4, 110.4, 
52.3, 40.7, 34.2, 32.1, 22.8, 22.1, 21.5, 14.1; HRMS (ESI-TOF) 
m/z: [M + H]+ calcd for C20H23N2O2  323.1760; Found, 323.1770. 
3-(Methoxymethyl)-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1h): 1-(6-methoxyhex-4-yn-1-yl)-1H-
indole-3-carbaldehyde (128 mg, 0.50 mmol), tert-butylamine (3.0 
mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), 
Cu(OAc)2 (197 mg, 2.1 equiv) and dichloroethane (3.0 mL) were 
employed. Upon silica gel column chromatography purification 
using MeOH in DCM gradient elution (0‒10%), compound 1h was 
isolated as a yellow solid (83 mg, 66%). M.p. 97‒99 °C; FTIR (thin 
film, cm−1) 2915, 2881, 2801, 1571, 1442; 1H NMR (400 MHz, 
CDCl3) δ 9.11 (s, 1H), 8.14 (dt, J = 7.8, 1.0 Hz, 1H), 7.52 (ddd, J = 
8.3, 7.2, 1.2 Hz, 1H), 7.42 (dt, J = 8.2, 0.9 Hz, 1H), 7.31 (ddd, J = 
8.1, 7.2, 1.0 Hz, 1H), 4.76 (s, 2H), 4.27 – 4.15 (m, 2H), 3.46 (s, 3H), 
3.15 (t, J = 6.2 Hz, 2H), 2.43 – 2.27 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 147.7, 142.9, 140.4, 139.6, 126.4, 121.5, 121.3, 120.3, 
117.4, 115.4, 108.8, 73.9, 58.4, 40.7, 22.1, 21.2; HRMS (ESI-TOF) 
m/z: [M + H]+ calcd for C16H17N2O 253.1341; Found, 253.1345. 
3-(3-((Tetrahydro-2H-pyran-2-yl)oxy)propyl)-5,6-dihydro-
4H-indolo[3,2,1-ij][1,6]naphthyridine (1i): 1-(8-((tetrahydro-2H-
pyran-2-yl)oxy)oct-4-yn-1-yl)-1H-indole-3-carbaldehyde (178 mg, 
0.50 mmol), tert-butylamine (3.0 mL), [Cp*Rh(MeCN)3](SbF6)2 
(C1, 10.6 mg, 2.5 mol %), Cu(OAc)2 (197 mg, 2.1 equiv) and di-
chloroethane (3.0 mL) were employed. Upon silica gel column 
chromatography purification using ethyl acetate in hexanes gradient 
elution (0‒50%), compound 1i was isolated as an orange oil (149 
mg, 85%). FTIR (thin film, cm−1) 2927, 1605, 1569, 1443, 1355, 
1322; 1H NMR (400 MHz, CDCl3) δ 9.07 (s, 1H), 8.16 – 8.07 (m, 
1H), 7.49 (ddd, J = 8.4, 7.1, 1.2 Hz, 1H), 7.39 (dt, J = 8.0, 0.9 Hz, 
1H), 7.33 – 7.28 (m, 1H), 4.66 – 4.55 (m, 1H), 4.26 – 4.17 (m, 2H), 
3.95 – 3.78 (m, 2H), 3.48 (dt, J = 9.8, 6.5 Hz, 2H), 3.12 – 2.94 (m, 
4H), 2.34 (m, 2H), 2.16 – 2.02 (m, 2H), 1.79 – 1.47 (m, 6H); 13C 
NMR (101 MHz, CDCl3) δ 152.6, 143.1, 142.5, 140.3, 139.9, 128.6, 
128.4, 126.1, 125.8, 121.7, 121.3, 120.2, 116.3, 113.4, 108.8, 40.7, 
36.0, 34.1, 31.5, 22.3, 21.6; HRMS (ESI-TOF) m/z: [M + H]+ calcd 
for C22H27N2O2 351.2067; Found, 351.2054. 
3-(3-Phenylpropyl)-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (1k): 1-(8-phenyloct-4-yn-1-yl)-1H-indole-3-
carbaldehyde (165 mg, 0.50 mmol), tert-butylamine (3.0 mL), 
[Cp*Rh(MeCN)3](SbF6)2 (C1, 10.6 mg, 2.5 mol %), Cu(OAc)2 (197 
mg, 2.1 equiv) and dichloroethane (3.0 mL) were employed. Upon 
silica gel column chromatography purification using ethyl acetate in 
hexanes gradient elution (0‒50%), compound 1k was isolated as an 
orange oil (142 mg, 87%). FTIR (thin film, cm−1) 2930, 1604, 1570, 
1497, 1444, 1321; 1H NMR (400 MHz, CDCl3) δ 9.10 (s, 1H), 8.14 
(dt, J = 7.8, 1.0 Hz, 1H), 7.51 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H), 7.41 
(dt, J = 8.1, 0.9 Hz, 1H), 7.34 – 7.27 (m, 4H), 7.26 – 7.17 (m, 3H), 
4.25 – 4.14 (m, 2H), 3.02 – 2.93 (m, 4H), 2.80 – 2.72 (m, 2H), 2.34 
(dq, J = 6.8, 5.8 Hz, 2H), 2.19 – 2.08 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 152.6, 143.1, 142.5, 140.3, 139.9, 128.6, 128.4, 126.1, 
125.8, 121.7, 121.3, 120.2, 116.3, 113.4, 108.8, 40.7, 36.0, 34.1, 
31.5, 22.3, 21.6; HRMS (ESI-TOF) m/z: [M + H]+ calcd for 
C23H23N2  327.1856; Found, 327.1822. 
1-n-Butyl-8,9-dihydro-7H-pyrrolo[3,2,1-ij][1,6]naphthyridine 
(1l): 1-(non-4-yn-1-yl)-1H-pyrrole-3-carbaldehyde (109 mg, 0.50 
mmol), tert-butylamine (3.0 mL), [Cp*Rh(MeCN)3](SbF6)2 (C1, 
10.6 mg, 2.5 mol %), Cu(OAc)2 (197 mg, 2.1 equiv) and dichloro-
ethane (3.0 mL) were employed. Upon silica gel column chroma-
tography purification using ethyl acetate in hexanes gradient elution 
(0‒50%), compound 1l was isolated as an orange oil (57 mg, 53%); 
FTIR (thin film, cm−1) 2951, 2928, 2869, 1670, 1619, 1460; 1H 
NMR (300 MHz, CDCl3) δ 8.71 (s, 1H), 7.04 (d, J = 3.1 Hz, 1H), 
6.47 (d, J = 3.1 Hz, 1H), 4.12 (t, J = 5.7 Hz, 2H), 2.95 (t, J = 6.2 Hz, 
2H), 2.84 (t, J = 7.8 Hz, 2H), 2.27 (quintet, J = 6.0 Hz, 2H), 1.79 – 
1.63 (m, 2H), 1.41 (dq, J = 14.6, 7.3 Hz, 2H), 0.94 (t, J = 7.3 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 148.1, 140.2, 138.9, 126.9, 
121.4, 113.8, 99.9, 43.6, 33.5, 32.3, 22.8, 22.7, 21.3, 14.1; HRMS 
(ESI-TOF) m/z: [M + H]+ calcd for C14H19N2  215.1548; Found, 
215.1556. 
Methyl 1-butyl-8,9-dihydro-7H-pyrrolo[3,2,1-
ij][1,6]naphthyridine-5-carboxylate (1m): methyl 4-formyl-1-
(non-4-yn-1-yl)-1H-pyrrole-2-carboxylate (138 mg, 0.50 mmol), 
tert-butylamine (3.0 mL, 1.50 mL/mmol), [Cp*Rh(MeCN)3](SbF6)2 
(C1, 10.6 mg, 2.50 mol%), Cu(OAc)2 (197 mg, 2.1 equiv) and di-
chloroethane (3.0 mL) were employed. Upon silica gel column 
chromatography purification using MeOH in DCM gradient elution 
(0‒10%), compound 1m was isolated as a yellow solid (105 mg, 
71%). M.p. 58‒60 °C; FTIR (thin film, cm−1) 2953, 2858, 1709, 
1614, 1436; 1H NMR (300 MHz, CDCl3) δ 8.80 (s, 1H), 7.23 (s, 
1H), 4.50 (t, J = 5.8 Hz, 2H), 3.92 (s, 3H), 2.94 (t, J = 6.2 Hz, 2H), 
2.85 (t, J = 7.8 Hz, 2H), 2.26 (quintet, J = 6.0 Hz, 2H), 1.70 (m, 
2H), 1.41 (dq, J = 14.5, 7.3 Hz, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) δ 162.2, 150.6, 142.7, 140.8, 127.8, 119.7, 
114.5, 108.4, 51.7, 43.7, 33.8, 32.1, 22.8, 22.8, 21.2, 14.0; HRMS 
(ESI-TOF) m/z: [M + H]+ calcd for C16H21N2O2  273.1603; Found, 
273.1610. 
Suzuki-Miyaura Coupling of Bromoisocanthine 1e 
3-n-Butyl-10-cyclopropyl-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (4a): To a 2-dram vial was added bromoi-
socanthine 1e (86 mg, 0.25 mmol), potassium cyclopropyltri-
fluoroborate (45 mg, 1.2 equiv), palladium(II) acetate (5.8 mg, 10 
mol %), di-(1-adamantyl)-n-butylphosphine (14.2 mg, 15 mol %), 
Cs2CO3 (245 mg, 3.0 equiv), PhMe (1.0 mL) and water (0.10 mL). 
The mixture was vacuumed and backfilled with nitrogen (×3) and 
heated to 100 ºC for 16 h. The mixture was cooled to 23 ºC, diluted 
with acetone (10 mL) and concentrated. The residue was purified by 
silica gel column chromatography using EtOAc in hexanes (0‒80%) 
as eluent to afford compound 4a as a pale yellow oil (32 mg, 42%).  
FTIR (thin film, cm−1) 2954, 2927, 2857, 1610, 1575; 1H NMR (400 
MHz, CDCl3) δ 9.05 (d, J = 0.7 Hz, 1H), 7.82 (dt, J = 1.5, 0.7 Hz, 
1H), 7.30 – 7.26 (m, 2H), 4.25 – 4.05 (m, 2H), 3.06 – 2.98 (m, 2H), 
2.98 – 2.86 (m, 2H), 2.33 (dq, J = 6.8, 5.8 Hz, 2H), 2.16 – 2.02 (m, 
1H), 1.80 – 1.70 (m, 2H), 1.50 – 1.38 (m, 2H), 1.04 – 0.99 (m, 2H), 
0.96 (t, J = 7.4 Hz, 3H), 0.80 – 0.74 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 143.4, 139.0, 138.8, 124.9, 121.7, 118.3, 115.9, 113.2, 
108.4, 103.2, 40.6, 32.1, 29.7, 22.8, 22.1, 21.5, 15.5, 14.1, 9.0; 
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C21H25N2 305.2018; 
Found, 305.2031. 
3-Butyl-10-(furan-2-yl)-5,6-dihydro-4H-indolo[3,2,1-
ij][1,6]naphthyridine (4b): To a 2-dram vial was added bromoi-
socanthine 1e (50 mg, 0.146 mmol), 2-furyl pinacol boronic ester 
(42 mg, 1.5 equiv), dichlorobis(di-t-
butylphenylphosphine)palladium(II) (4.8 mg, 5 mol %), K3PO4•H2O 
(67 mg, 2.0 equiv), THF (0.50 mL) and water (0.10 mL). The mix-
ture was vacuumed and backfilled with nitrogen (×3) and heated to 
65 ºC for 5 h. The mixture was cooled to room temperature, diluted 
with acetone (10 mL) and concentrated. The residue was purified by 
silica gel column chromatography using EtOAc in hexanes (0‒80%) 
as eluent to afford compound 4c as a pale yellow solid (38 mg, 
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79%). M.p. 95‒96 °C; FTIR (thin film, cm−1) 3073, 2947, 2865, 
1612, 1567, 1440; 1H NMR (300 MHz, CDCl3) δ 9.09 (s, 1H), 8.40 
(d, J = 1.6 Hz, 1H), 7.79 (dd, J = 8.5, 1.7 Hz, 1H), 7.49 (d, J = 1.8 
Hz, 1H), 7.35 (d, J = 8.5 Hz, 1H), 6.67 (dd, J = 3.4, 0.8 Hz, 1H), 
6.51 (dd, J = 3.3, 1.8 Hz, 1H), 4.17 (t, J = 5.8 Hz, 2H), 3.02 (t, J = 
6.2 Hz, 2H), 2.96 – 2.77 (m, 2H), 2.34 (p, J = 6.0 Hz, 2H), 1.74 (tt, 
J = 7.9, 6.5 Hz, 2H), 1.45 (sextet, J = 7.3 Hz, 2H), 0.97 (t, J = 7.3 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 154.8, 153.6, 143.4, 141.4, 
140.0, 139.5, 123.6, 122.4, 121.9, 116.5, 116.1, 113.2, 111.7, 108.8, 
103.6, 40.6, 34.3, 32.1, 22.9, 22.1, 21.5, 14.1; HRMS (ESI-TOF) 
m/z: [M + H]+ calcd for C22H23N2O 331.1810; Found, 331.1819. 
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